Skip to main content
. 2022 Dec 21;18(11):3086–3098. doi: 10.1111/jth.15072

Table 3.

Coagulation parameters in normal pregnancy (third trimester) and possible alterations in COVID‐19 in association with pregnancy

Laboratory parameter Normal values
Possible alterations in pregnancy with COVID‐19 Potential prognostic markers Levels reported in severe COVID‐19 outside pregnancya
Third trimester of pregnancy Non‐ pregnant women
PT 8.5–11.0 seconds 16.0 seconds
  • Unlabelled ImageCOVID coagulopathy Or DIC

  • PPH

Yes 3 s extension
>6 in 47.6% of non‐survivors with DIC compared to 3 in survivors
APTT 25.5–42.5 seconds 27.0–37.0 seconds
  • Unlabelled ImageCOVID coagulopathy Or DIC

  • PPH

  • Consumption events

  • Unlabelled ImageFVIII release

Yes 5 s extension
D‐dimer 0.16–1.7 μg/mL
  • Unlabelled ImageCOVID coagulopathy Or DIC

  • Unlabelled ImageAcute phase reactant

  • VTE

  • Trauma

  • Liver/ renal disease

Yes (severe disease and in hospital mortality
Cut off: 2.0 μg/mL)
2.12 in non survivors Vs 0.61 in survivors
>3 in 86% non‐survivors with DIC
Platelet count
Mean (range)
Third trimester Delivery PP
  • Unlabelled ImageCOVID coagulopathy Or DIC

  • Unlabelled ImagePPH

  • Cytokines induced

Yes
Thrombocytopenia (severe disease + mortality)
<100 in 33% of non‐survivors
<50 in 24% non‐survivors with DIC
225 (57–505) × 109/L 217 (63–552) × 109/L 264 (91–575) × 109/L 273 (111–999) × 109/L
Fib 2.48–5.06 g/L 2.5–4.0 g/L
  • Unlabelled ImageCOVID coagulopathy Or DIC

  • Unlabelled ImageAcute phase reactant

  • Inflammation

  • Unlabelled ImagePPH

Yes 5.16 in non survivors vs 4.5 in survivors (non signifcant difference)
<1 in 29% non‐survivors with DIC
FDPs <15 μg/mL 3.09 ± 1.96 μg/mL
  • Unlabelled ImageCOVID coagulopathy Or DIC

  • Acute phase reactant

7.6 in non survivors vs 4.0 in survivors

Note

Please note this table is a guide. Age and ethnic variations exist and need to be considered. References:30., 34., 39., 40., 43., 89..

Abbreviations: APTT, activated partial thromboplastin time; DIC, disseminated intravascular coagulopathy; FDPs, fibrin degradation products; Fib, fibrinogen; PP, post partum; PT, prothrombin time; VTE, venous thromboembolism.

a

Reference:30; 71% of non‐survivors developed DIC (ISTH DIC score of ≥5) vs 0.6% of survivors.